NFL Biosciences Logo

NFL Biosciences

ISIN: FR0014003XT0 | Ticker: ALNFL | LEI: 9695006VJWNTN4UNHA27
Sector: Health CareSub-Industry: Biotechnology
Country: France

About NFL Biosciences

Company Description

Making it possible to cure smoking addiction

NFL Biosciences develops a naturally based addiction withdrawal solution to help smokers willing to quit in their battle for a healthier life.

NFL Biosciences is a biotechnology company pioneering innovative solutions through a breakthrough approach based on a standardized extract of tobacco leaf. NFL-101 is NFL Biosciences current core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

Year founded

2006

Served area

Worldwide

Headquarters

199 Rue Hélène Boucher, 34170 Castelnau-le-Lez – France

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Capital markets information

ISIN

FR0014003XT0

LEI

9695006VJWNTN4UNHA27

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.